BETA
LED photobiomodulation and facial imaging technology for plastic surgery practices.
Elixir MD is a privately held medical technology company based in Irvine, California, United States. Its company profile reports a 2023 founding. The business focuses on photobiomodulation for plastic surgery practices and also promotes EVA 3D facial imaging for consultations and surgical planning.
Its ELIXIR MD LED device uses four light bands and is marketed through branded perioperative and skin maintenance protocols. FDA cleared the device in July 2024 for specified dermatological and temporary pain-relief uses. That decision does not establish the broader advertised claims about faster surgical healing or reduced complications. EVA 3D is a separate offering with manufacturer-reported pilot use; its U.S. authorization status was not established.
Athré Facial Plastics in Houston publicly documents using Elixir MD before surgery and during recovery, providing a named example of practice adoption. The manufacturer also announced an Australia/New Zealand subsidiary and an exclusive partnership with High Tech Medical in August 2025. These sources document use and a sales channel rather than comparative clinical outcomes or market share.
The ELIXIR MD LED platform has FDA clearance K241293 under Yassen Wellness. Its labeled dermatologic uses must be distinguished from broader postoperative-healing marketing. EVA 3D is a separate visualization offering and does not inherit the LED device’s clearance. [7][3][8][9][14]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [16][17]
Latest recorded source review: 2026-10-20.
Scope: selected product families.
Documented commercial product families.
Panel-based light therapy using red, blue, yellow and infrared wavelengths. Branded protocols organize the same platform for perioperative and aesthetic workflows. [9][3][4][5]
FDA-clearedOffered through manufacturer and clinical practices, including Athré Facial Plastics.
Company-promoted 3D facial visualization for consultation and surgical planning, with an iPhone/iPad app published by ELIXIR MD INC. [1][6]
Marketed · regulatory scope variesCompanion app publicly listed; manufacturer reports pilot clinical integrations. Broader hardware availability not established.
Publicly documented relationships; coverage may be incomplete.
| Partner | Territory / scope | Products |
|---|---|---|
| High Tech Medical Pty Ltd [13] | Australia and New Zealand | ELIXIR MD LED photobiomodulation device |
Sources checked October 17, 2026.
Manufacturer announced an ANZ subsidiary and exclusive High Tech Medical partnership. Local regulatory authorizations were not reviewed. [13]
FDA issued K241293 to Yassen Wellness LLC for specified dermatological and temporary pain-relief indications. [2]
Accessed 10/20/2026